Moreover, GM-CSF and its induced macrophage polarization have been suggested to be the potential therapeutic targets in RA, psoriatic arthritis and all types of undifferentiated arthritis in patients (62). The gene discussed is CSF2; the disease is rheumatoid arthritis.